Related Experiment Videos
Allergic bronchopulmonary aspergillosis: an increasing clinical problem
Postgraduate Medicine
|November 1, 1975
Summary
Allergic bronchopulmonary aspergillosis (ABPA) is increasingly diagnosed in the US. This condition involves hypersensitivity reactions and is effectively treated with adrenal corticosteroids.
Area of Science:
- Pulmonology
- Immunology
- Mycology
Background:
- Allergic bronchopulmonary aspergillosis (ABPA) is a complex lung disease.
- It is increasingly recognized in the United States population.
Observation:
- ABPA presents with recurrent fever, cough, wheezing, and characteristic sputum plugs.
- Pulmonary infiltrates, eosinophilia, and dual skin reactions are key indicators.
- Presence of antibodies to Aspergillus in blood confirms diagnosis.
Findings:
- The pathogenesis involves both type I and type III hypersensitivity reactions.
- Aspergillus fumigatus is implicated in the immune response.
Implications:
- Adrenal corticosteroids demonstrate efficacy in managing ABPA.
- Early recognition and diagnosis are crucial for effective treatment.